We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+34.87%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.6B
AUM Growth
+$2.27B
Cap. Flow
-$278M
Cap. Flow %
-2.4%
Top 10 Hldgs %
30.23%
Holding
354
New
65
Increased
75
Reduced
125
Closed
74

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$106M
2
META icon
Meta Platforms (Facebook)
META
+$106M
3
PYPL icon
PayPal
PYPL
+$105M
4
XLNX
Xilinx Inc
XLNX
+$99.5M
5
CIEN icon
Ciena
CIEN
+$86.3M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$85.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$84.6M
3
AMZN icon
Amazon
AMZN
+$72.7M
4
INTC icon
Intel
INTC
+$72.2M
5
RNG icon
RingCentral
RNG
+$71.8M

Sector Composition

Rank Sector Weight
1 Technology 36.14%
2 Healthcare 19.11%
3 Financials 17.15%
4 Communication Services 12.94%
5 Consumer Discretionary 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECH icon
301
Bio-Techne
TECH
$11.2B
– –
-5,776
Closed -$274K
VZ icon
302
Verizon
VZ
$194B
– –
-743,194
Closed -$39.9M
WDAY icon
303
Workday
WDAY
$39.1B
– –
-260,327
Closed -$33.9M
ZBH icon
304
Zimmer Biomet
ZBH
$18B
– –
-377,310
Closed -$37M
ZYME icon
305
Zymeworks
ZYME
$1.61B
– –
-965,151
Closed -$34.2M
CTLT
306
DELISTED
CATALENT, INC.
CTLT
– –
-198,209
Closed -$10.3M
SAVE
307
DELISTED
Spirit Airlines, Inc.
SAVE
– –
-274,076
Closed -$3.53M
SRCL
308
DELISTED
Stericycle Inc
SRCL
– –
-534,786
Closed -$26M
SIEN
309
DELISTED
Sientra, Inc.
SIEN
– –
-278,441
Closed -$5.54M
ORTX
310
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-35,000
Closed -$2.64M
COUP
311
DELISTED
Coupa Software Incorporated
COUP
– –
-52,765
Closed -$7.37M
TWTR
312
DELISTED
Twitter, Inc.
TWTR
– –
-1,311,038
Closed -$32.2M
CCXI
313
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-250,920
Closed -$10.1M
TPTX
314
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-79,157
Closed -$3.54M
CALA
315
DELISTED
Calithera Biosciences, Inc
CALA
– –
-25,000
Closed -$2.22M
ZNGA
316
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-1,258,810
Closed -$8.62M
PVG
317
DELISTED
PRETIUM RESOURCES INC.
PVG
– –
-929,375
Closed -$5.27M
KL
318
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
– –
-296,868
Closed -$11M
MSON
319
DELISTED
Misonix Inc
MSON
– –
-427,027
Closed -$4.02M
PFPT
320
DELISTED
Proofpoint, Inc.
PFPT
– –
-397,232
Closed -$40.8M
PRAH
321
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-125,732
Closed -$10.4M
HMSY
322
DELISTED
HMS Holdings Corp.
HMSY
– –
-14,754
Closed -$373K
PFNX
323
DELISTED
Pfenex Inc.
PFNX
– –
-123,033
Closed -$1.08M
STML
324
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-1,316,106
Closed -$6.37M
9 10 11 12
13

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Polar Capital held 354 positions worth $11.6B, up 24% from $9.31B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Polar Capital's Q2 2020 filing shows 65 new, 75 increased, 125 reduced and 74 closed positions. Its largest new stake was TripAdvisor: 3,886,053 shares worth $73.9M. The largest sale was AbbVie, an estimated $85.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q2 2020 buy was TripAdvisor: 3,886,053 shares worth $73.9M.
  • Polar Capital added most to UnitedHealth in Q2 2020, an estimated $106M increase.
  • Polar Capital's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $84.6M.
  • Polar Capital fully exited AbbVie in Q2 2020, selling an estimated $85.6M.
  • Polar Capital's ten largest holdings make up 30% of its $11.6B portfolio in Q2 2020.
  • Polar Capital opened 65 new positions and closed 74 in Q2 2020.
  • Polar Capital's portfolio value rose 24% quarter-over-quarter to $11.6B.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.